Search alternatives:
progress » process (Expand Search)
Showing 12,541 - 12,560 results of 12,642 for search 'detection (progress OR programs)', query time: 0.23s Refine Results
  1. 12541

    Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma by Lilan Yi, Lilan Yi, Yinfang Gu, Yinfang Gu, Longhua Guo, Longhua Guo, Xiaofang Zou, Xiaofang Zou, Guowu Wu, Guowu Wu

    Published 2025-02-01
    “…Flow cytometry was employed to detect the expression of CD3, CD4, CD8, CD56, and CD19 on peripheral blood cells. …”
    Get full text
    Article
  2. 12542

    Human adenovirus type 7 (HAdV-7) infection induces pulmonary vascular endothelial injury through the activation of endothelial autophagy by Zhihe Chen, Zhongying Yang, Lifen Rao, Changgen Li, Na Zang, Enmei Liu

    Published 2024-12-01
    “…Additionally, evidence of leaky lung blood vessels and ALI was observed, including progressive weight loss, elevated pulmonary vascular permeability, and severe lung consolidation. …”
    Get full text
    Article
  3. 12543

    Mechanisms of impaired expression of p53-responsive microRNA genes in diffuse B-large cell lymphoma by E. N. Voropaeva, T. I. Pospelova, M. I. Churkina, A. A. Gurazheva, O. V. Berezina, V. N. Maksimov

    Published 2023-10-01
    “…A more in-depth description of molecular events that disrupt the functioning of the p53 signaling pathway is important for understanding the mechanisms of formation and progression of diffuse B-large cell lymphoma (DCCL), as well as its sensitivity to treatment. …”
    Get full text
    Article
  4. 12544

    Predicting clinical outcomes at hospital admission of patients with COVID-19 pneumonia using artificial intelligence: a secondary analysis of a randomized clinical trial by Caio César Souza Conceição, Camila Marinelli Martins, Mayck Medeiros Silva, Hugo Caire de Castro Faria Neto, Davide Chiumello, Davide Chiumello, Davide Chiumello, Patricia Rieken Macedo Rocco, Fernanda Ferreira Cruz, Pedro Leme Silva

    Published 2025-05-01
    “…The analysis assessed clinical, laboratory, and blood markers at admission to predict clinical improvement, defined as a two-point increase on the World Health Organization clinical progression scale after 7 days. LASSO and CombiROC were used to select optimal predictive variables. …”
    Get full text
    Article
  5. 12545

    Automated Image-Based Wound Area Assessment in Outpatient Clinics Using Computer-Aided Methods: A Development and Validation Study by Kuan-Chen Li, Ying-Han Lee, Yu-Hsien Lin

    Published 2025-06-01
    “…This objective and practical method can aid clinical decision-making by tracking wound progression over time.…”
    Get full text
    Article
  6. 12546

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    “…The primary endpoint was the objective response rate (ORR), while secondary endpoints included progression-free survival (PFS), duration of response (DOR), disease control rate (DCR), clinical benefit rate (CBR), safety, plasma pharmacokinetics (PK), and biomarker analysis. …”
    Get full text
    Article
  7. 12547
  8. 12548

    Therapeutic time window of sodium of Danshensu on cerebral ischemia and its mechanism of inhibiting oxidative stress and ferroptosis through Nrf2 pathway by Chao Guo, Zhongying Ma, Xingru Tao, Kai Gao, Wei Zhang, Aidong Wen, Yi Ding, Jingwen Wang

    Published 2025-07-01
    “…Ferroptosis exerts a crucial feature in the development and progression of IS. Nuclear factor-E2-related factor 2 (Nrf2) can positively regulate the transcription of Recombinant Solute Carrier Family 7, member 11 (SLC7A11) and glutathione peroxidase (GPX4) genes that combat lipid peroxidation in ferroptosis. …”
    Get full text
    Article
  9. 12549

    The Influence of Non-Alc oholic Fatty Liver Disease on Indicators of Arterial Stiffness and Risk of Cardiovascular Complications in Patients with Arterial Hypertension by M. E. Statsenko, A. M. Streltsova, M. I. Turovets

    Published 2020-07-01
    “…To determine the value of concomitant non-alcoholic fatty liver disease in patients with arterial hypertension in the progression of rigidity of the main arteries and in increase of risk of cardiovascular complications. …”
    Get full text
    Article
  10. 12550

    Peri-coronary adipose tissue attenuation and its association with plaque vulnerability and clinical outcomes in coronary artery disease using combined CCTA and OCT by Caifeng Yang, Chancui Deng, Jie Xia, Sha Wang, Long Zhang, Zhijiang Liu, Wei Zhang, Yi Deng, Shiwan Lu, Guanxue Xu, Bei Shi

    Published 2025-05-01
    “…Abstract Vascular inflammation plays a pivotal role in the pathogenesis of atherosclerotic plaques, driving their progression from a stable to an unstable phenotype. …”
    Get full text
    Article
  11. 12551

    Features of Development and Course of Disseminated Intravascular Coagulation Syndrome During Surgical Interventions in Children with Oncological Diseases by N. P. Leonov, V. V. Schukin, G. A. Novichkova, M. A. Maschan, F. I. Ataullakhanov, S. S. Yashin, A. M. Zeynalov, Е. A. Spiridonova

    Published 2020-07-01
    “…The extreme expression of the «organ» type DIC is the progression of thrombotic syndrome to life threatening complications, which reduces the 90-day survival by 12%.…”
    Get full text
    Article
  12. 12552
  13. 12553

    Is it true that lower PTH control is associated with lower levels of inflammatory cytokines in patients with chronic kidney disease? by Xu Qin, Wang Shasha, Xiong Qiuyue, Wang Ning, Hu Yifeng, Yan Lei, Cao Huixia, Shao Fengmin

    Published 2025-12-01
    “…Background The body of patients with chronic kidney disease (CKD)is in a state of microinflammation, which further aggravates the progression of CKD and the occurrence and development of its complications. …”
    Get full text
    Article
  14. 12554

    Culture, self-esteem and menstrual hygiene management among adolescent girls in Uganda: the impact of economic and family strengthening by Flavia Namuwonge, Samuel Kizito, Vicent Ssentumbwe, Phionah Namatovu, Florence Namuli, Nhial T. Tutlam, Proscovia Nabunya, Fred M. Ssewamala

    Published 2025-05-01
    “…No significant moderation by menstrual hygiene knowledge or cultural attitude was detected. Conclusion The YDA + MFG intervention and natural age progression improved self-esteem, though reliance on self-reported data may introduce bias. …”
    Get full text
    Article
  15. 12555
  16. 12556
  17. 12557
  18. 12558

    ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS by Tatiyana Valentinovna Popkova, T A Panafidina, D S Novikova, E N Aleksandrova, A A Novikov, T E Novoselova, A N Gerasimov, E L Nasonov

    Published 2014-02-01
    “…Cardiovascular events caused by early development and rapid progression of atherosclerotic vascular disease are the main reason behind early lethality among patients with systemic lupus erythematosus (SLE). …”
    Get full text
    Article
  19. 12559

    Application of machine learning in early childhood development research: a scoping review by Akbar K Waljee, Amina Abubakar, Patrick N Mwangala, Faith Neema Benson, Daisy Chelangat, Willie Brink, Cheryl A Moyer

    Published 2025-08-01
    “…Artificial intelligence techniques, particularly machine learning (ML), offer an innovative approach by analysing complex datasets to detect subtle developmental patterns.Objective To map the existing literature on the use of ML in ECD research, including its geographical distribution, to identify research gaps and inform future directions. …”
    Get full text
    Article
  20. 12560

    Role of Digoxin in Preventing Cigarette Smoke-Induced COPD via HIF-1α Inhibition in a Mouse Model by Zhang K, Zhou F, Zhu C, Yuan L, Li D, Wang J, Lu W

    Published 2025-05-01
    “…Therefore, in the present study, we chose digoxin as the inhibitor to investigate whether HIF-1α contributes to the progression in a mouse model of COPD and possible mechanism.Methods: The COPD model was established by cigarette smoke (CS) exposed; animals were intragastrically treated with vehicle or different doses of digoxin (0.02 mg/kg and 0.1 mg/kg). …”
    Get full text
    Article